Education
About Us
Working with TipRanks
Follow Us
Althea Group Holdings Ltd. (AU:AGH)
:AGH
RESEARCH TOOLSreports
AGH Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.05
Previous CloseN/A
Volume191.55K
Average Volume (3M)2.41M
Market Cap
AU$23.85M
Enterprise ValueAU$30.25M
Total Cash (Recent Filing)AU$563.00K
Total Debt (Recent Filing)AU$6.96M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding822,575,400
10 Day Avg. Volume5,696,838
30 Day Avg. Volume2,412,270
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)43.18
Price to Sales (P/S)0.00
P/FCF Ratio-3.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Althea Group Holdings Ltd. News
PremiumCompany Announcements
Althea Group’s Peak Canada Launches Own-Brand THC Beverage Line
PremiumCompany Announcements
Althea Group to Issue Over 20 Million New Securities
PremiumCompany Announcements
Althea Group Holdings Shifts Focus to North American THC Beverage Market
PremiumCompany Announcements
Althea Group Holdings Updates Head Office Contact Number
PremiumCompany Announcements
Althea Group Holdings Shifts Focus to THC Beverages for Growth
PremiumCompany Announcements
Althea Group Holdings Shifts Focus to THC-Infused Beverages
PremiumCompany Announcements
Althea Group Holdings Appoints New CFO to Drive Financial GrowthOptions Prices
Currently, No data available
---
Ownership Overview
7.91% Insiders
―
Mutual Funds
― Other Institutional Investors
92.09% Public Companies and
Individual Investors
AGH FAQ
What was Althea Group Holdings Ltd.’s price range in the past 12 months?
Althea Group Holdings Ltd. lowest share price was AU$0.02 and its highest was AU$0.05 in the past 12 months.
What is Althea Group Holdings Ltd.’s market cap?
Althea Group Holdings Ltd.’s market cap is AU$23.85M.
When is Althea Group Holdings Ltd.’s upcoming earnings report date?
Althea Group Holdings Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 41 days.
How were Althea Group Holdings Ltd.’s earnings last quarter?
Currently, no data Available
Is Althea Group Holdings Ltd. overvalued?
According to Wall Street analysts Althea Group Holdings Ltd.’s price is currently Overvalued.
Does Althea Group Holdings Ltd. pay dividends?
Althea Group Holdings Ltd. does not currently pay dividends.
What is Althea Group Holdings Ltd.’s EPS estimate?
Althea Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Althea Group Holdings Ltd. have?
Althea Group Holdings Ltd. has 822,575,400 shares outstanding.
What happened to Althea Group Holdings Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Althea Group Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:AGH
Althea Group Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:AGH Sentiment 70%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$120.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.00%
12-Months-Change
Fundamentals
Return on Equity
-218.38%
Trailing 12-Months
Asset Growth
-36.02%
Trailing 12-Months
Company Description
Althea Group Holdings Ltd.
Althea Group Holdings Ltd. (AGH) is an Australian-based company operating in the pharmaceutical sector, specifically focusing on the development, production, and sales of medicinal cannabis products. The company provides a range of cannabis-based medicines and is involved in the entire supply chain from cultivation to distribution. AGH's core offerings include various forms of cannabis products that are utilized for medical purposes, catering to patients with specific therapeutic needs.